Search Within

Bone Marrow Transplant

Formats
  1. Meeting Abstract (1531)
  2. Journal Article (1197)
  3. Review (75)
  4. Research Letter (48)
  5. Book Section (34)
  6. Guidelines (26)
  7. Editorial (24)
  8. Correspondence (18)
  9. Conference Paper (14)
  10. Book Whole (1)
  11. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (2969)
  2. Department of Medicine (2969)
  3. Hematologic Malignancies, Division of (2846)
  4. Survivorship Research (1387)
  5. GSK Faculty (931)
  6. CTCR Scholars (872)

More Groups

People
  1. Sergio Giralt (1067)
  2. Miguel-Angel Perales (942)
  3. Sean Devlin (469)
  4. Ann Jakubowski (458)
  5. Gunjan Shah (446)
  6. Heather Landau (435)

More People

Years
  1. 2025 (66)
  2. 2024 (212)
  3. 2023 (263)
  4. 2022 (201)
  5. 2021 (177)
  6. 2020 (208)

More Years

Publications
  1. Blood (887)
  2. Biology of Blood and Marrow Transplantation (516)
  3. Bone Marrow Transplantation (175)
  4. Journal of Clinical Oncology (127)
  5. Transplantation and Cellular Therapy (113)
  6. Blood Advances (94)

More Publications

Publishers
  1. American Society of Hematology (988)
  2. Elsevier Inc. (766)
  3. Nature Publishing Group (261)
  4. American Society of Clinical Oncology (130)
  5. Wiley Blackwell (66)
  6. Taylor & Francis Group (65)

More Publishers

Results (2969)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Acupuncture improves certain aspects of sleep in hematopoietic stem cell transplantation patients: A secondary analysis of a randomized controlled trial
    Journal Article

    El Iskandarani, S.; Sun, L.; Li, S. Q.; Pereira, G.; Giralt, S.; Deng, G.
    Acupuncture in Medicine (2023)

    Fulltext@MSK | Save
  • Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing
    Journal Article

    Ptashkin, R. N.; Ewalt, M. D.; Jayakumaran, G.; Kiecka, I.; Bowman, A. S.; Yao, J. J.; Casanova, J.; Lin, Y. T. D.; Petrova-Drus, K.; Mohanty, A. S.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Circulating microbial cell–free DNA is increased during neutropenia after hematopoietic stem cell transplantation
    Journal Article

    Blair, L. M.; Akhund-Zade, J.; Katsamakis, Z. A.; Smibert, O. C.; Wolfe, A. E.; Giardina, P.; Slingerland, J.; Bercovici, S.; Perales, M. A.; Taur, Y.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Residual mutant hematopoietic stem cells drives post-transplant relapse of the myelodysplastic syndromes
    Meeting Abstract

    Kroger, B.; Son, A.; Huang, Y.; Patel, P.; Afrough, A.; Kaur, G.; Anderson, L.; Awan, F.; Ramakrishnan, P.; Verma, K.; more...
    Experimental Hematology (2023)

    Fulltext@MSK | Save
  • Idecabtagene vicleucel (ide-cel) versus standard regimens in patients with triple-class-exposed (TCE) relapsed and refractory multiple myeloma (RRMM): KarMMa-3, A phase III randomized controlled trial (RCT)
    Meeting Abstract

    Giralt, S.; Ailawadhi, S.; Arnulf, B.; Patel, K.; Cavo, M.; Nooka, A. K.; Manier, S.; Callander, N.; Costa, L. J.; Vij, R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Idecabtagene vicleucel (ide-cel) versus standard regimens in patients with triple-class-exposed (TCE) relapsed and refractory multiple myeloma (RRMM): A KarMMa-3 analysis in high-risk subgroups
    Meeting Abstract

    Patel, K.; Rodríguez-Otero, P.; Manier, S.; Baz, R.; Raab, M. S.; Cavo, M.; Callander, N.; Costa, L. J.; Moreau, P.; Solomon, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • The randomized Phase III SIERRA (Study of Iomab-B in Elderly relapsed or refractory AML) trial: Successful allogeneic hematopoietic stem cell transplantation using treatment with Iomab-B-led regimen for patients with active, relapsed or refractory AML with failed targeted therapies
    Meeting Abstract

    Nath, R.; Seropian, S.; Choe, H.; Litzow, M. R.; Abboud, C.; Koshy, N.; Stiff, P. J.; Tomlinson, B.; Abhyankar, S.; Foran, J. M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Outcomes in B-cell precursor acute lymphoblastic leukaemia patients receiving inotuzumab ozogamicin prehaematopoietic stem cell transplantation
    Meeting Abstract

    Marks, D.; de Lima, M.; Kebriaei, P.; Lanza, F.; Cho, C.; Popradi, G.; Zhang, M. J.; Zhang, F.; Welch, V.; Tikka, S.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Veno-occlusive disease risk and other outcomes in patients with B-cell precursor acute lymphoblastic leukemia who received inotuzumab ozogamicin and proceeded to hematopoietic stem cell transplantation: A registry-based, observational study
    Meeting Abstract

    Stelljes, M.; de Lima, M.; Kebriaei, P.; Lanza, F.; Cho, C.; Popradi, G.; Zhang, M. J.; Zhang, F.; Welch, V.; Tikka, S.; more...
    Annals of Hematology (2023)

    Fulltext@MSK | Save
  • Should patients with AML and active disease be transplanted?
    Meeting Abstract

    Gyurkocza, B.
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save